Apotex Delivers Strong Second Quarter 2027 Results and Raises FY2027 Guidance

Apotex reports quarterly profit of $100.8-million, raises guidance for full year

Revenue totalled $852.9-million in second quarter, up from $843.5-million in the same quarter last year

Apotex reports Q2 profit, raises guidance for revenue growth for the year

TORONTO - Apotex Health Corp. raised its guidance for its full year as it reported a second-quarter profit of $100.8 million, up from $82.9 million a year earlier.

Apotex Delivers Strong Second Quarter 2027 Results and Raises FY2027 Guidance

/PRNewswire/ -- Apotex Health Corp. ("Apotex" or the "Company") (TSX: APTX), a Canadian-based global health company and Canada's largest pharmaceutical...